Department of Justice February 2014 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II
Document Number: 2014-04333
Type: Proposed Rule
Date: 2014-02-27
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to reschedule hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act. This proposed action is based on a rescheduling recommendation from the Assistant Secretary for Health of the Department of Health and Human Services and an evaluation of all other relevant data by the DEA. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule II controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess) or propose to handle hydrocodone combination products.
Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV
Document Number: 2014-04332
Type: Rule
Date: 2014-02-27
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration (DEA) places the substance 5[alpha]- pregnan-3[alpha]-ol-11,20-dione (alfaxalone), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities with, or possess) or propose to handle alfaxalone and substances containing alfaxalone.
Policy Regarding Obtaining Information From, or Records of, Members of the News Media; and Regarding Questioning, Arresting, or Charging Members of the News Media
Document Number: 2014-04239
Type: Rule
Date: 2014-02-27
Agency: Department of Justice, Office of the Attorney General
This rule amends the policy of the Department of Justice regarding the use of subpoenas, certain court orders, and search warrants, to obtain information from, or records of, members of the news media. The rule also amends the Department's policy regarding questioning, arresting, or charging members of the news media.
Meeting of the National Coordination Committee on the AI/AN SANE-SART Initiative
Document Number: 2014-04072
Type: Notice
Date: 2014-02-25
Agency: Department of Justice, Office of Justice Programs
The National Coordination Committee on the American Indian/ Alaska Native (AI/AN) Sexual Assault Nurse Examiner (SANE)-Sexual Assault Response Team (SART) Initiative (``National Coordination Committee'' or ``Committee'') will meet to carry out its mission to provide valuable advice to assist the Office for Victims of Crime (OVC) to promote culturally relevant, victim-centered responses to sexual violence within AI/AN communities.
Agency Information Collection Activities: Proposed Collection; Comments Requested: ATF Adjunct Instructor Data Form
Document Number: 2014-03965
Type: Notice
Date: 2014-02-25
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
Agency Information Collection Activities: Proposed Collection; Comments Requested; Annual Firearms Manufacturing and Exportation Report
Document Number: 2014-03962
Type: Notice
Date: 2014-02-25
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
Agency Information Collection Activities: Proposed Collection; Comments Requested: Supplemental Information on Water Quality Considerations
Document Number: 2014-03948
Type: Notice
Date: 2014-02-25
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
Advisory Board; Notice of Meeting
Document Number: 2014-03790
Type: Notice
Date: 2014-02-24
Agency: Department of Justice, National Institute of Corrections
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Odva, Inc.
Document Number: 2014-03625
Type: Notice
Date: 2014-02-20
Agency: Antitrust Division, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested: FFL Out-of-Business Records Request
Document Number: 2014-03414
Type: Notice
Date: 2014-02-18
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
Searches of Housing Units, Inmates, and Inmate Work Areas: Use of X-ray Devices-Clarification of Terminology
Document Number: 2014-03240
Type: Proposed Rule
Date: 2014-02-14
Agency: Department of Justice, Bureau of Prisons
In this document, the Bureau of Prisons (Bureau) proposes to clarify that body imaging search devices are ``electronic search devices'' for routine or random use in searching inmates, and are distinguished from medical x-ray devices, which require the inmate's consent, or Regional Director approval, for use as search devices.
Schedules of Controlled Substances: Placement of Suvorexant into Schedule IV
Document Number: 2014-03124
Type: Proposed Rule
Date: 2014-02-13
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to place the substance suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7- methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2- yl)phenyl]methanone), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act (CSA). This proposed scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess), or propose to handle suvorexant.
Sunshine Act Meeting
Document Number: 2014-03145
Type: Notice
Date: 2014-02-12
Agency: Foreign Claims Settlement Commission, Department of Justice
Pilot Project for Tribal Jurisdiction Over Crimes of Domestic Violence-Announcement of Successful Applications
Document Number: 2014-03023
Type: Notice
Date: 2014-02-12
Agency: Department of Justice
The Associate Attorney General, exercising authority delegated by the Attorney General, is granting the requests of three Indian tribes to be designated as participating tribes under section 204 of the Indian Civil Rights Act of 1968, as amended, on an accelerated basis, under the voluntary pilot project described in section 908(b)(2) of the Violence Against Women Reauthorization Act of 2013.
Notice of Lodging Proposed Consent Decree
Document Number: 2014-02861
Type: Notice
Date: 2014-02-11
Agency: Department of Justice
Schedules of Controlled Substances: Temporary Placement of Four Synthetic Cannabinoids Into Schedule I
Document Number: 2014-02848
Type: Rule
Date: 2014-02-10
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule four synthetic cannabinoids into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA). The substances are: Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB- 22; QUPIC); quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22); N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA); and N-(1-amino- 3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxam ide (ADB- PINACA). This action is based on a finding by the Deputy Administrator that the placement of these synthetic cannabinoids and their optical, positional, and geometric isomers, salts and salts of isomers into schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities, and possess), or propose to handle these synthetic cannabinoids.
Importer of Controlled Substances; Notice of Application; Catalent CTS, Inc.
Document Number: 2014-02597
Type: Notice
Date: 2014-02-07
Agency: Drug Enforcement Administration, Department of Justice
Importation of Arms, Ammunition and Implements of War and Machine Guns, Destructive Devices, and Certain Other Firearms; Extending the Term of Import Permits (2010R-26P)
Document Number: 2014-02580
Type: Rule
Date: 2014-02-07
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
This rule amends the regulations of the Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF) to extend the standard term of import permits for firearms, ammunition, and defense articles from 1 year to 2 years. The additional time will allow importers sufficient time to complete the importation of the authorized commodity. In addition, it will eliminate the need for the importer to submit a new import application, ATF Form 6, where the importation was not completed within the 1-year period. Extending the term of import permits will result in a substantial cost and time savings for both the industry and ATF, and will not cause any discernible adverse effects. This rulemaking proceeding is included in the Department of Justice's retrospective review plan developed pursuant to Executive Order 13563, ``Improving Regulation and Regulatory Review.''
Importer of Controlled Substances; Notice of Registration; Penick Corporation
Document Number: 2014-02209
Type: Notice
Date: 2014-02-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey Pharmaceutical Materials, Inc.
Document Number: 2014-02208
Type: Notice
Date: 2014-02-04
Agency: Drug Enforcement Administration, Department of Justice